JP2019518073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518073A5 JP2019518073A5 JP2019508309A JP2019508309A JP2019518073A5 JP 2019518073 A5 JP2019518073 A5 JP 2019518073A5 JP 2019508309 A JP2019508309 A JP 2019508309A JP 2019508309 A JP2019508309 A JP 2019508309A JP 2019518073 A5 JP2019518073 A5 JP 2019518073A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- chrimson
- fused
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662329692P | 2016-04-29 | 2016-04-29 | |
| US62/329,692 | 2016-04-29 | ||
| PCT/IB2017/000663 WO2017187272A1 (en) | 2016-04-29 | 2017-04-28 | Optogenetic visual restoration using chrimson |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518073A JP2019518073A (ja) | 2019-06-27 |
| JP2019518073A5 true JP2019518073A5 (https=) | 2020-05-07 |
| JP6942789B2 JP6942789B2 (ja) | 2021-09-29 |
Family
ID=59253830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508309A Active JP6942789B2 (ja) | 2016-04-29 | 2017-04-28 | Ｃｈｒｉｍｓｏｎを用いた光遺伝学的視覚回復 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190269755A1 (https=) |
| EP (1) | EP3448411A1 (https=) |
| JP (1) | JP6942789B2 (https=) |
| KR (1) | KR102466887B1 (https=) |
| CN (1) | CN110267673B (https=) |
| AU (2) | AU2017256910B2 (https=) |
| CA (1) | CA3025975A1 (https=) |
| WO (1) | WO2017187272A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016094850A1 (en) | 2014-12-12 | 2016-06-16 | The Trustees Of The University Of Pennsylvania | Methods of Promoting Nervous System Regeneration |
| EP3442409A4 (en) | 2016-04-14 | 2019-11-13 | The Trustees of The University of Pennsylvania | IMPLANTABLE LIVING ELECTRODES AND METHOD FOR USE THEREOF |
| EP3693061A1 (en) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Method for controlling an optogenetic device using filtering and associated devices |
| EP3693060A1 (en) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Method for controlling an optogenetic device using a command law for the radiant power of a light source and associated devices |
| EP3733139A1 (en) | 2019-05-02 | 2020-11-04 | Gensight Biologics | Viewing apparatus and method for projecting a light signal |
| WO2021132903A1 (ko) * | 2019-12-26 | 2021-07-01 | 고려대학교 산학협력단 | 광유전학 기법을 이용한 알츠하이머 질환 뇌에서의 뇌파 손상 회복 방법 |
| US20250235585A1 (en) * | 2022-02-18 | 2025-07-24 | The Trustees Of The University Of Pennsylvania | Tissue Engineered Spinal Tracts For Functional Regeneration After Spinal Cord Injury |
| EP4568710A1 (en) | 2022-08-11 | 2025-06-18 | Institute Of Molecular And Clinical Ophthalmology Basel (Iob) | Human cone photoreceptor optogenetic constructs |
| CN119827471B (zh) * | 2025-02-14 | 2025-10-03 | 中山大学中山眼科中心 | 一种体内追踪外段蛋白运输的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10216005A1 (de) | 2002-04-11 | 2003-10-30 | Max Planck Gesellschaft | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| EP1919497B1 (en) | 2005-07-22 | 2020-02-12 | The Board of Trustees of the Leland Stanford Junior University | Light-activated cation channel and uses thereof |
| CN101484005A (zh) * | 2006-05-04 | 2009-07-15 | 韦恩州立大学 | 通过向体内递送视紫红质核酸恢复视觉响应 |
| EP1891976A1 (en) | 2006-08-23 | 2008-02-27 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research | Use of light sensitive genes |
| CN101980668A (zh) * | 2008-02-07 | 2011-02-23 | 赛拉基因公司 | 通过玻璃体内施用编码治疗用蛋白质的表达载体救援光感器 |
| MX2010011467A (es) | 2008-04-18 | 2011-02-15 | Novartis Forschungsstiftung | Novedosas herramientas y metodos terapeuticos para tratar la ceguera. |
| CN105755044A (zh) | 2011-04-22 | 2016-07-13 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体及其使用方法 |
| WO2013071231A1 (en) | 2011-11-12 | 2013-05-16 | Massachusetts Institute Of Technology | Channelrhodopsins for optical control of cells |
| WO2015161308A1 (en) * | 2014-04-18 | 2015-10-22 | Massachusetts Institute Of Technology | Mutant channelrhodopsins with altered ion selectivity |
| US10882892B2 (en) * | 2014-08-05 | 2021-01-05 | Massachusetts Institute Of Technology | Channelrhodopsin variants and uses thereof |
| EP3371572B1 (en) * | 2015-11-05 | 2021-05-05 | Inscopix, Inc. | System for optogenetic imaging |
| WO2017093566A1 (en) * | 2015-12-04 | 2017-06-08 | Universite Pierre Et Marie Curie (Paris 6) | Promoters and uses thereof |
-
2017
- 2017-04-28 WO PCT/IB2017/000663 patent/WO2017187272A1/en not_active Ceased
- 2017-04-28 CA CA3025975A patent/CA3025975A1/en active Pending
- 2017-04-28 EP EP17734136.9A patent/EP3448411A1/en active Pending
- 2017-04-28 CN CN201780041321.8A patent/CN110267673B/zh active Active
- 2017-04-28 AU AU2017256910A patent/AU2017256910B2/en active Active
- 2017-04-28 KR KR1020187034650A patent/KR102466887B1/ko active Active
- 2017-04-28 JP JP2019508309A patent/JP6942789B2/ja active Active
- 2017-04-28 US US16/097,204 patent/US20190269755A1/en not_active Abandoned
-
2022
- 2022-07-07 AU AU2022204884A patent/AU2022204884A1/en not_active Abandoned
-
2023
- 2023-09-05 US US18/461,035 patent/US20240165198A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518073A5 (https=) | ||
| Emptoz et al. | Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G | |
| Igarashi et al. | Direct comparison of administration routes for AAV8-mediated ocular gene therapy | |
| Ou et al. | Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer | |
| Holscher | Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease | |
| CN109661471B (zh) | 启动子及其用途 | |
| Ratican et al. | Progress in gene therapy to prevent retinal ganglion cell loss in glaucoma and Leber’s hereditary optic neuropathy | |
| JP2015523379A5 (https=) | ||
| JP2015510759A5 (https=) | ||
| JP2016528202A5 (https=) | ||
| WO2017187272A8 (en) | Optogenetic visual restoration using chrimson | |
| NZ704275A (en) | Aav-mediated gene therapy for rpgr x-linked retinal degeneration | |
| HRP20211024T4 (hr) | Aav vektori za gensku terapiju mrežnice i cns-a | |
| FI3795181T3 (fi) | Amd:n hoito aav2-variantilla ja afliberseptillä | |
| JP2019523648A5 (https=) | ||
| JP2014500717A5 (https=) | ||
| JP2010501501A (ja) | 光感受性遺伝子の使用 | |
| WO2015158749A3 (de) | Viraler vektor für den zielgerichteten gentransfer in gehirn und rückenmark | |
| WO2015138628A8 (en) | Use of aav-expressed m013 protein as an anti-inflammatory therapeutic | |
| HRP20191945T1 (hr) | Poboljšana il-6-protutijela | |
| JP2017523239A5 (https=) | ||
| Talla et al. | Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE | |
| Ku et al. | Retinal gene therapy: current progress and future prospects | |
| JP2021528407A5 (https=) | ||
| EA202092069A1 (ru) | Композиции и способы лечения макулярной дистрофии |